0001553878-15-000029.txt : 20151113 0001553878-15-000029.hdr.sgml : 20151113 20151113163645 ACCESSION NUMBER: 0001553878-15-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151111 FILED AS OF DATE: 20151113 DATE AS OF CHANGE: 20151113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 300 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STARR KEVIN P CENTRAL INDEX KEY: 0001192603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 151229638 MAIL ADDRESS: STREET 1: 75 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2015-11-11 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001192603 STARR KEVIN P 300 THIRD STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2015-11-11 4 M 0 25000.0 9.3 A 25000 D Common Stock 2015-11-11 4 M 0 12500.0 11.33 A 37500 D Common Stock 2015-11-11 4 S 0 2274.0 105.3117 D 35226 D Common Stock 2015-11-11 4 S 0 4027.0 106.4611 D 31199 D Common Stock 2015-11-11 4 S 0 12606.0 107.3901 D 18593 D Common Stock 2015-11-11 4 S 0 15499.0 108.2258 D 3094 D Common Stock 2015-11-11 4 S 0 3094.0 109.1417 D 0 D Common Stock 2015-11-12 4 M 0 12500.0 11.33 A 12500 D Common Stock 2015-11-12 4 M 0 25000.0 15.82 A 37500 D Common Stock 2015-11-12 4 S 0 35400.0 100.0135 D 2100 D Common Stock 2015-11-12 4 S 0 1200.0 101.5825 D 900 D Common Stock 2015-11-12 4 S 0 900.0 103.0089 D 0 D Stock Option (right to buy) 11.33 2015-11-11 4 M 0 12500.0 0.0 D 2013-06-21 2022-06-21 Common Stock 12500 12500 D Stock Option (right to buy) 11.33 2015-11-12 4 M 0 12500.0 0.0 D 2013-06-21 2022-06-21 Common Stock 12500 0 D Stock Option (right to buy) 15.82 2015-11-12 4 M 0 25000.0 0.0 D 2011-06-02 2020-06-02 Common Stock 25000 0 D Stock Option (right to buy) 9.3 2015-11-11 4 M 0 25000.0 0.0 D 2012-06-09 2021-06-09 Common Stock 25000 0 D The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2015. Sale prices ranged from $104.85 to $105.70. Sale prices ranged from $105.86 to $106.85. Sale prices ranged from $106.88 to $107.875. Sale prices ranged from $107.88 to $108.81. Sale prices ranged from $108.92 to $109.62. Sale prices ranged from $100.00 to $100.85. Sale prices ranged from $101.02 to $101.92. Sale prices ranged from $102.67 to $103.44. The option vested, in full, on the first anniversary of the Grant Date. By: /s/ Michael P. Mason, Attorney-In-Fact For: Kevin P. Starr 2015-11-13